Q: If not yet asked your comments on CN earnings please
5i Research Answer:
CNR is now trading at 19X Forward P/E. In the 2Q, CNR’s revenue grew 7% to $4.33B, slightly missing the estimates of $4.38B and EPS of $1.84 missed estimates of $1.93. The operating results slightly missed expectations. The balance sheet has an OK net debt/EBITDA of 2.5x. The company continues to repurchase shares aggressively and pay healthy dividends. Overall, results missed expectations but management is still expected to compound diluted EPS in the range of 10%-15% over the 2024-2026 period along with a healthy ROIC. We think CNR’s long-term fundamentals remain intact.